Spain Halitosis Treatment Market

ID: MRFR/HC/54797-HCR 200 Pages Satyendra Maurya Last Updated: September 17, 2026
Spain Halitosis Treatment Market Research Report: Size, Share, Trend Analysis By Indication (Respiratory, Liver, Kidney, Gastrointestinal, Systemic, Others), By Diagnostic Tests (Halimeter, Gas Chromatography, BANA Test, -Galactosidase Activity Assay, Others) and By Drug Treatment (Antacids, Antiseptics, Ranitidine, Others) - Growth Outlook & Industry Forecast 2025 To 2035
Spain Halitosis Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)10.55%
2024 Market Size$ 122.25 Million
2025 Market Size$ 135.15 Million
2035 Market Size$ 368.48 Million
Key Players
Procter & Gamble
Colgate-Palmolive
Unilever
Johnson & Johnson
GlaxoSmithKline
Henkel
Trends
  • Rising Demand for Natural Products
  • Increased Awareness of Oral Hygiene
  • Diverse Product Offerings
Opportunities
  • Growing Health Consciousness
  • Rising Influence of Social Media
  • Aging Population and Oral Health Needs
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Indication (USD Million)
      1. 4.1.1 Respiratory
      2. 4.1.2 Liver
      3. 4.1.3 Kidney
      4. 4.1.4 Gastrointestinal
      5. 4.1.5 Systemic
      6. 4.1.6 Others
    2. 4.2 Medical Device, BY Diagnostic Tests (USD Million)
      1. 4.2.1 Halimeter
      2. 4.2.2 Gas Chromatography
      3. 4.2.3 BANA Test
      4. 4.2.4 Β-Galactosidase Activity Assay
      5. 4.2.5 Others
    3. 4.3 Medical Device, BY Drug Treatment (USD Million)
      1. 4.3.1 Antacids
      2. 4.3.2 Antiseptics
      3. 4.3.3 Ranitidine
      4. 4.3.4 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Procter & Gamble (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Colgate-Palmolive (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Unilever (GB)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Johnson & Johnson (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 GlaxoSmithKline (GB)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Henkel (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Church & Dwight (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Listerine (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SPAIN MARKET ANALYSIS BY INDICATION
    3. 6.3 SPAIN MARKET ANALYSIS BY DIAGNOSTIC TESTS
    4. 6.4 SPAIN MARKET ANALYSIS BY DRUG TREATMENT
    5. 6.5 KEY BUYING CRITERIA OF MEDICAL DEVICE
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF MEDICAL DEVICE
    8. 6.8 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    10. 6.10 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    11. 6.11 MEDICAL DEVICE, BY INDICATION, 2024 (% SHARE)
    12. 6.12 MEDICAL DEVICE, BY INDICATION, 2024 TO 2035 (USD Million)
    13. 6.13 MEDICAL DEVICE, BY DIAGNOSTIC TESTS, 2024 (% SHARE)
    14. 6.14 MEDICAL DEVICE, BY DIAGNOSTIC TESTS, 2024 TO 2035 (USD Million)
    15. 6.15 MEDICAL DEVICE, BY DRUG TREATMENT, 2024 (% SHARE)
    16. 6.16 MEDICAL DEVICE, BY DRUG TREATMENT, 2024 TO 2035 (USD Million)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY INDICATION, 2025-2035 (USD Million)
      2. 7.2.2 BY DIAGNOSTIC TESTS, 2025-2035 (USD Million)
      3. 7.2.3 BY DRUG TREATMENT, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Spain Halitosis Treatment Market Segmentation

Spain Halitosis Treatment Market By Indication (USD Million, 2025-2035)

  • Respiratory
  • Liver
  • Kidney
  • Gastrointestinal
  • Systemic
  • Others

Spain Halitosis Treatment Market By Diagnostic Tests (USD Million, 2025-2035)

  • Halimeter
  • Gas Chromatography
  • BANA Test
  • Β-Galactosidase Activity Assay
  • Others

Spain Halitosis Treatment Market By Drug Treatment (USD Million, 2025-2035)

  • Antacids
  • Antiseptics
  • Ranitidine
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.